Skip to content
Home/Companies/Biotech/Outpost Bio
Outpost Bio

Outpost Bio

Biotech·United Kingdom·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Outpost Bio?

Outpost Bio is a British Biotech company, currently owned by Merantix Capital since 2025.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
Merantix Capital
Investor
Merantix Capital
Merantix Capital AI Fund · 2026 · VC

Key facts

HQUnited Kingdom
SectorBiotech
StatusActive
Websitewww.outpost.bio

More from Merantix Capital AI Fund

Other portfolio companies in the same fund.

WhyBrilliant
Active
SoftwareGermany· 2026
Arqh
Active
LogisticsSwitzerland· 2025
Droidrun
Droidrun
Active
SoftwareGermany· 2025
Ficus Health
Active
HealthTechGermany· 2024
Graph Therapeutics
Active
BiotechAustria· 2024
revel8
revel8
Active
CybersecurityGermany· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Outpost Bio?

Outpost Bio is currently owned by Merantix Capital, through Merantix Capital AI Fund, since 2025.

When did Merantix Capital acquire Outpost Bio?

Merantix Capital acquired Outpost Bio in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue